医学
重症监护室
肾功能
万古霉素
内科学
降钙素原
病危
槽水位
人口统计学的
观察研究
重症监护医学
败血症
移植
人口学
细菌
他克莫司
社会学
金黄色葡萄球菌
生物
遗传学
作者
Jinlan Wang,H. F. Wang,Mengyao Shi,Jianan Xu,Liying Huang,Qin Li,S. Q. Liu,Yingzi Huang
出处
期刊:PubMed
[National Institutes of Health]
日期:2019-08-01
卷期号:58 (8): 572-576
标识
DOI:10.3760/cma.j.issn.0578-1426.2019.08.005
摘要
Objective: To assess the rate achieving the target vancomycin trough level (VTL) and its influencing factors in critically ill patients. Methods: The retrospective observational study recruited adult patients treated with intravenous vancomycin in the intensive care unit (ICU) at Zhongda Hospital from January 2015 to December 2017. Serum VTL was tested at steady state. Patients' demographics, the sites of infection, microbial culture results, the severity of illness, laboratory data and vancomycin regimen were obtained at the baseline. The rate achieving target VTL (15-20 mg/L) was analyzed based on renal function. Linear regression was performed to determine the influencing factors of VTL. Results: A total of 85 patients were enrolled, among whom only 23.5% (20/85) achieved the target VTL. In patients with normal renal function, the achieving rate was only 11.4% (4/35), and 80.0% (28/35) was lower than the target trough level multiple linear regression analysis showed that procalcitonin (PCT), estimated glomerular filtration rate (eGFR) and acute physiology and chronic health disease classification system Ⅱ (APACHE Ⅱ) score were independent factors associated with VTL. Conclusion: Achieving target VTL in critically ill patients is not satisfactory. Further study to optimize the administration is needed to facilitate prompt attainment of target VTL.
科研通智能强力驱动
Strongly Powered by AbleSci AI